Search

Your search keyword '"Anne, Vincent Salomon"' showing total 685 results

Search Constraints

Start Over You searched for: Author "Anne, Vincent Salomon" Remove constraint Author: "Anne, Vincent Salomon"
685 results on '"Anne, Vincent Salomon"'

Search Results

1. Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes

2. Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp

3. CD74 supports accumulation and function of regulatory T cells in tumors

4. EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition

5. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

6. Reporting on invasive lobular breast cancer in clinical trials: a systematic review

7. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

8. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease

9. The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features

10. Obesity-associated changes in molecular biology of primary breast cancer

11. Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers

12. Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience

13. Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

14. CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade

15. Definition of a novel breast tumor-specific classifier based on secretome analysis

16. Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies

17. A catalog of numerical centrosome defects in epithelial ovarian cancers

18. Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma

19. Value of the loss of heterozygosity to BRCA1 variant classification

20. Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes

21. HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

22. Timing evolution of lobular breast cancer through phylogenetic analysis

23. The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer

24. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas

25. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

26. Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients

27. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study

28. Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer

29. Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial

30. Prediction of Treatment Response in Triple Negative Breast Cancer From Whole Slide Images

32. PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

33. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer

34. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients

35. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms

36. Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

37. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports

38. Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression

39. Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial

40. Evolution of synchronous female bilateral breast cancers and response to treatment

41. Distinct expression profiles and functions of Kindlins in breast cancer

42. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX

43. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers

44. miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers

45. Next‐generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction

46. Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression

47. APCgermline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?

49. CD74 supports Treg accumulation and function in tumors

Catalog

Books, media, physical & digital resources